Snap-on (NYSE: SNA) CEO exercises options and sells 22,889 shares
Rhea-AI Filing Summary
For Snap-on Inc (SNA), Chairman, President and CEO Nicholas T. Pinchuk reported a series of transactions on 2026-08-18. He exercised 33,750 stock options for Common Stock at an exercise price of $168.7000 per share, described as a Rule 16b-3 stock option exercise pursuant to a Rule 10b5-1 Plan adopted on November 3, 2025.
On the same date he sold an aggregate of 22,889 shares of Common Stock in multiple open-market transactions at weighted average prices between approximately $397.12 and $402.21, with each sale leg reported separately. Footnotes state that a portion of the option shares was sold to cover the exercise price and estimated tax liability, and that detailed trade breakdowns are available upon request.
Following these transactions, Mr. Pinchuk continues to hold substantial equity-based awards in Snap-on, including multiple tranches of stock options on Common Stock with exercise prices ranging from $155.3400 to $378.5500 and expirations from 2028 to 2036, as well as restricted stock units, performance units, and deferred stock units linked on a 1-for-1 basis to Snap-on Common Stock.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
24 txns
Insider
PINCHUK NICHOLAS T
Role
Chairman, President and CEO
Sold
22,889 shs ($9.15M)
Approx. gross sale proceeds
$9.15M
Approx. exercise cost
$5.69M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1, F10, F9 | 33,750 | -- | -- |
| Exercise | Common Stock F1, F2 | 33,750 | $168.70 | $5.69M |
| Sale | Common Stock F1, F3 | 600 | $397.5012 | $239K |
| Sale | Common Stock F1, F4 | 7,475 | $399.0133 | $2.98M |
| Sale | Common Stock F1, F5 | 9,720 | $399.6002 | $3.88M |
| Sale | Common Stock F1, F6 | 3,454 | $400.7276 | $1.38M |
| Sale | Common Stock F1, F7 | 1,640 | $401.925 | $659K |
| holding | Stock Option (Right to Buy) F9 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F9 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F9 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F9 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F9 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F9 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F11 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F11 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F11 | -- | -- | -- |
| holding | Restricted Stock Units F12, F13 | -- | -- | -- |
| holding | Restricted Stock Units F12, F13 | -- | -- | -- |
| holding | Restricted Stock Units F12, F13 | -- | -- | -- |
| holding | Performance Units F12, F14 | -- | -- | -- |
| holding | Performance Units F12, F15 | -- | -- | -- |
| holding | Performance Units F12, F16 | -- | -- | -- |
| holding | Deferred Stock Units F12, F17, F8 | -- | -- | -- |
| holding | Common Stock F8 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 450,814 shares (Direct);
Common Stock — 867,778.9587 shares (Direct);
Restricted Stock Units — 14,054 shares (Direct);
Performance Units — 42,161 shares (Direct);
Deferred Stock Units — 26,585.9551 shares (Direct);
Common Stock — 875.0682 shares (Indirect, By 401(k) Plan)
Footnotes (17)
- F1. The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025.
- F2. Includes 0.0061 shares acquired under a dividend reinvestment plan.
- F3. This transaction was executed in multiple trades at prices ranging from $397.12 to $398.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- F4. This transaction was executed in multiple trades at prices ranging from $398.29 to $399.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- F5. This transaction was executed in multiple trades at prices ranging from $399.29 to $400.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- F6. This transaction was executed in multiple trades at prices ranging from $400.30 to $401.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- F7. This transaction was executed in multiple trades at prices ranging from $401.47 to $402.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- F8. This information is based on a plan statement dated June 30, 2026.
- F9. Option fully vested.
- F10. Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025.
- F11. Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.
- F12. 1 for 1.
- F13. The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.
- F14. If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
- F15. If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
- F16. If the Company achieves certain goals over the 2026-2028 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
- F17. Payment will be made in accordance with the reporting person's deferral election, death, disability or termination of employment.
Key Figures
Options exercised: 33,750.0000 shares
Exercise price: $168.7000 per share
Shares sold: 22,889 shares
+4 more
7 metrics
Options exercised
33,750.0000 shares
Stock options for Common Stock exercised at $168.7000 per share on 2026-08-18
Exercise price
$168.7000 per share
Exercise of Stock Option (Right to Buy) into 33,750 shares of Common Stock
Shares sold
22,889 shares
Aggregate Common Stock sales on 2026-08-18 across five Form 4 sale entries
Sale prices
$397.5012–$401.9250 per share
Weighted average prices for open-market Common Stock sales on 2026-08-18
Remaining option strike range
$155.3400–$378.5500
Exercise prices of reported remaining Stock Option (Right to Buy) grants on Common Stock
Deferred Stock Units
26,585.9551 units
Deferred Stock Units linked 1-for-1 to Common Stock, reported as direct holdings
Indirect 401(k) holdings
875.0682 shares
Common Stock held indirectly by 401(k) Plan as of June 30, 2026
Key Terms
Rule 10b5-1 Plan, Rule 16b-3, Restricted Stock Units, Performance Units, +1 more
5 terms
Rule 10b5-1 Plan regulatory
"option was exercised, and a portion of the underlying shares were sold to cover"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
Rule 16b-3 regulatory
"Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
Restricted Stock Units financial
"The restricted stock units vest three years from the grant date"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Performance Units financial
"If the Company achieves certain goals over the 2024-2026 period, the performance units"
Performance units are company awards that become valuable only if specified business targets are met; they typically convert into shares or cash when performance goals are achieved. Think of them like a conditional bonus that turns into stock only if the company hits agreed milestones, so they align managers’ incentives with shareholders’ interests and can affect future share count, executive pay expense, and investor returns.
Deferred Stock Units financial
"Payment will be made in accordance with the reporting person's deferral election"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
FAQ
What did Snap-on (SNA) CEO Nicholas Pinchuk report in this Form 4?
Nicholas T. Pinchuk reported exercising 33,750 stock options for Snap-on Common Stock at $168.7000 per share and selling 22,889 shares in multiple open-market transactions at weighted average prices around $397–$402, all on 2026-08-18.
At what price did the Snap-on (SNA) CEO exercise his stock options?
On 2026-08-18, Nicholas T. Pinchuk exercised 33,750 stock options for Snap-on Common Stock at an exercise price of $168.7000 per share. A footnote describes this as a Rule 16b-3 stock option exercise under a Rule 10b5-1 Plan adopted November 3, 2025.
Were the Snap-on (SNA) CEO’s transactions under a Rule 10b5-1 trading plan?
Yes. The filing’s checkbox indicates Rule 10b5-1 status, and footnotes state the option exercise and related sales were made pursuant to a Rule 10b5-1 Plan adopted on November 3, 2025, with some shares sold to cover exercise price and estimated tax liability.
What equity awards does the Snap-on (SNA) CEO still hold after these transactions?
Nicholas T. Pinchuk continues to hold multiple stock option grants on Snap-on Common Stock with exercise prices from $155.3400 to $378.5500 and expirations through 2036, plus restricted stock units, performance units, and deferred stock units that convert 1-for-1 into Common Stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
